No abstract

is currently researching an AHRC collaborative doctoral award examining the role and value of sport in museums. She works as a freelance cultural consultant and is an assessor for the Associateship of the Museums Association (AMA). Justine began her career at the BBC and Granada Television before joining the museums sector. Holding posts at National Museums, Liverpool and the National Media Museum, Bradford, Justine developed a passion for how museums can support learning and engage new audiences. She headed the BBC's outreach programme in Yorkshire, before joining the Museums, Libraries, and Archives Council as a Regional Learning Manager.

This study led to the development of a parametric design method for mass-customised head/face products. A systematic review of different approaches for mass customization was conducted, identifying advantages and limitations for their application to new product development. A parametric modelling algorithm of a 3D human face was developed using selected scanned 3D head models. The algorithm was developed from a set of measurable and adjustable parameter points related to the facial geometry. These parameters were defined using planimetry. Using the assigned parameter values as input, the parametric model generated 3D models of a human face that served as a reference for the design of customized eyewear. The current challenges and opportunities of mass customized head/face products are described, along with the possibilities for new parametric product design approaches to enable rapid manufacturing and mass customization. This study also explored whether a new parametric design framework for mass customization could be effectively implemented as an early-stage new product development strategy for head/face products.

No abstract

Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a common dose-limiting side-effect of taxane-based chemotherapy, causing progressive and often irreversible pain/sensitivity in the hands and feet. Prevention/treatments for CIPN are not well-developed and urgently needed. Limb cryocompression during chemotherapy has demonstrated promising early data of preventing/reducing CIPN severity. Currently there are no medical devices available that are dedicated to the specific requirements of CIPN prevention. As part of our ongoing development of a dedicated CIPN-prevention limb cryocompression system, this study documents the design & development of the wearable arm wrap, a central component of the system, from initial concept to a trial-ready prototype. A collaborative and multidisciplinary approach was adopted to address the complex and high-risk nature of this SME (Small Medium Enterprise)-centered medical device design & development process. The complementary collaboration unites multidisciplinary expertise spanning the scope of the project. Alongside the clinical, academic, and design & development expertise, the integration of commercial expertise is imperative to promote the market viability, and ultimate success, of the development. As the global leading experts in scalp cooling specializing in the prevention of chemotherapy-induced alopecia, UK-based SME Paxman Coolers Ltd is optimally positioned to support the commercial and regulatory dimensions. Development and adoption of a novel mixed-methodology (HudPAX) facilitated the integration of evidence-based and user-centered techniques to optimize the design & development approach and ensure integration of all critical design inputs. Alpha prototypes were designed through evidence-based approaches, with data from existing clinical trials utilized to determine the preliminary design inputs, alongside 3D ergonomic data. Investigations utilized computer-aided design, rapid prototyping, additive manufacturing, sketch modeling, and fast ideation. User-based approaches facilitated stakeholder-feedback through expert focus groups, informing further design & development and projecting the design into the next stage, Beta prototyping, for use in large-scale efficacy trials and upscaling manufacturing. This paper demonstrates a novel mixed-methods approach, which promotes cross-sector multidisciplinary collaboration, to address the complex multi-layered challenges posed by an early-stage medical device design & development process.